UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of November, 2023
Commission File Number: 001-41106
Incannex Healthcare Limited
(Exact name of Registrant as specified in its charter)
not applicable
(Translation of Registrant’s name into English)
Australia
(Jurisdiction of incorporation or organization)
Joel Latham
Chief Executive Officer and Managing Director
Level
39, Rialto South Tower
525 Collins Street
Melbourne 3000
Australia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On November 17, 2023, The Australian Securities Exchange filed an announcement captioned: “Suspension from Official Quotation”, a copy of which announcement is attached to this Form 6-K as Exhibit 99.1.
1
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Incannex Healthcare Limited | ||
| Date: November 17, 2023 | By: | /s/ Joel Latham |
| Name: | Joel Latham | |
| Title: | Chief Executive Officer and Managing Director | |
2
INDEX TO EXHIBITS
| Exhibit No. | ||
| 99.1 | ASX Announcement, dated November 17, 2023 - Suspension from Official Quotation |
3
Exhibit 99.1
 |
Market Announcement
17 November 2023
Incannex Healthcare Limited (ASX: IHL) – Suspension from Quotation
Description
The securities of Incannex Healthcare Limited (‘IHL’) will be suspended from quotation at the close of trading on Friday, 17 November 2023 under Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with ASIC approving the scheme of arrangement by which Incannex Healthcare Inc. will acquire all of the issued securities in IHL.
Issued by
Melissa Kostopoulos
Senior Adviser, Listings Compliance
| 17 November 2023 | Market Announcement 1/1 | |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |